Breaking News: Daraxonrasib Approved for Pancreatic Cancer
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
When I was a child, the proximity of the Jersey Shore to my hometown made the beach a frequent...
Welcome to Cancer Research Catalyst, the official blog of the American Association for Cancer Research (AACR). With this blog,...